Cilo Cybin Holdings (JSE:CCC) EBIT : R Mil (TTM As of Mar. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Cilo Cybin Holdings EBIT?

Cilo Cybin Holdings's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2023 was R-0.54 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cilo Cybin Holdings's annualized ROC % for the quarter that ended in Mar. 2023 was -289.25%. Cilo Cybin Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2023 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Cilo Cybin Holdings EBIT Historical Data

The historical data trend for Cilo Cybin Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cilo Cybin Holdings EBIT Chart

Cilo Cybin Holdings Annual Data

Trend

Mar22

Mar23

EBIT

-0.54

Cilo Cybin Holdings Semi-Annual Data
	Mar22	Mar23
EBIT	-	-0.54

Competitive Comparison of Cilo Cybin Holdings's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cilo Cybin Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cilo Cybin Holdings's EV-to-EBIT falls into.

Cilo Cybin Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was R Mil.

Cilo Cybin Holdings (JSE:CCC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cilo Cybin Holdings's annualized ROC % for the quarter that ended in Mar. 2023 is calculated as:

	ROC % (Q: Mar. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2022 )	+	Invested Capital (Q: Mar. 2023 ))	/ count )
=	-0.538 * ( 1 - 0% )	/	( (0	+	0.372)	/ 2 )
=	-0.538	/	0.186
=	-289.25 %

where

	Invested Capital		(Q: Mar. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.01	-	0	-	( 0.01	-	max(0, 0	-	0.01	+	0.01	))
=	0

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.077	-	0.247	-	( 0.077	-	max(0, 0.619	-	0.077	+	0.077	))
=	0.372

Note: The Operating Income data used here is one times the annual (Mar. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Cilo Cybin Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2022		Q: Mar. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.54	/	( ( (0 + max(0, 0))	+	(0 + max(-0.317, 0)) )	/	2 )
=	-0.54	/	( ( 0	+	0 )	/	2 )
=	-0.54	/	0
=	%

where Working Capital is:

	Working Capital		(Q: Mar. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0	+	0	+	0)
=	0

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0.247	+	0	+	0.07)
=	-0.317

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cilo Cybin Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2023 )
	=		/	234.584
	=	%

Cilo Cybin Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Cilo Cybin Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cilo Cybin Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cilo Cybin Holdings Ltd (JSE:CCC) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Sterling Street, The Point Office Park, Unit C1, Samrand, Pretoria, GT, ZAF, 0157

Website

https://www.cilocybin.com

Cilo Cybin Holdings Ltd is a Company whose core focus is on supplying GMP medical cannabis products, including GMP CBD, CBG, CBN isolates and GMP THC and CBD distillates to meet the highest standards of quality, effectiveness, care, and safety. It specializes in supplying medical-grade cannabis flower and final products, using a cold ethanol extraction process with high-quality input materials.

Cilo Cybin Holdings Headlines

No Headlines